But sales of Spiriva, approved in chronic obstructive pulmonary disease and asthma, have declined by almost 15% although it is still BI’s biggest drug, generating sales of around 3 billion euros.
The researchers looked at the most commonly used anticholinergic drug classes, including antidepressants, first-generation antihistamines, and bladder antimuscarinics. The study involved 3 434 ...